CLINICAL_TRIALS
trial_result
· 2017-02-17
Clinical Trial Update: Antineoplaston Therapy in Treating Patients With Ependymoma [Phase 2]
Summary
Phase 2 trial update on antineoplaston therapy for ependymoma; study terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Burzynski Research Institute | Conditions: Ependymoma | Phase 2 | Status: TERMINATED | Results posted: 2017-02-17